65862-713Level 3
Atazanavir Sulfate (Atazanavir)
**Product type:** Human Prescription Drug
**Active ingredient:** ATAZANAVIR SULFATE
**Strength:** 300 mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Aurobindo Pharma Limited
**Marketing category:** ANDA (ANDA204806)
**Pharmacologic class:** Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/65862-713Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.